Redeye: Stillfront Group - The next level!
Stillfront had a CMD (Capital Markets Day) on the 27th of November. One of the main topics of the CMD was the new financial goals for 2022. We argue that Stillfront goals are ambitious, but also at the same time reachable. Following the strong development by Stillfront, shown synergies, impressions from the CMD, and raised margin goals, we have increased our long-term profitability assumptions, which leads to an increased Base-case. It seems like Stillfront is entering the next phase (level up!) as a company, and the valuation will likely follow suit.
Read more and download the research update: http://bit.ly/34Qsti1
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/